GlassScriptPhysician profile
Banu Mahalingham
NPI 1417904509
$1,625.21
in general payments reported to CMS, 2019-2025
21 companies · $31.23 in 2025
The $31.23 reported for 2025 was less than what a typical provider received nationally.
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $697 · 2020: $192 · 2021: $218 · 2022: $183 · 2023: $136 · 2024: $168 · 2025: $31.23.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $335.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $335.26 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Amgen INC. | $312.75 | 2019-2024 | Repatha |
| Janssen Pharmaceuticals, INC | $218.27 | 2019-2021 | |
| Kowa Pharmaceuticals America, INC. | $207.54 | 2019-2022 | |
| E.R. Squibb & Sons, L.L.C. | $140.60 | 2019-2022 | |
| Esperion Therapeutics, INC. | $131.19 | 2020-2024 | Nexletol |
| Sanofi-Aventis U.S. LLC | $96.95 | 2019-2022 | |
| Novartis Pharmaceuticals Corporation | $79.35 | 2019-2020 | |
| Abbott Laboratories | $62.41 | 2019-2024 | Jot Dx |
| Astrazeneca Pharmaceuticals LP | $55.51 | 2019 | |
| Edwards Lifesciences Corporation | $44.94 | 2019 | |
| Philips North America LLC | $44.68 | 2024 | (5044) Mcot |
| Boehringer Ingelheim Pharmaceuticals, INC. | $42.50 | 2019-2020 | |
| Novo Nordisk INC | $31.23 | 2025 | Wegovy |
| Pfizer INC. | $27.37 | 2019 | |
| Merck Sharp & Dohme LLC | $27.01 | 2021 |
Show all 21 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Regeneron Healthcare Solutions, INC. | $26.93 | 2019 | |
| Preventice Services, LLC | $16.43 | 2019 | |
| Boston Scientific Corporation | $16.16 | 2019 | |
| Astellas Pharma US INC | $14.63 | 2019 | |
| Irhythm Technologies, INC. | $14.40 | 2024 | Zio Xt Patch, Zio Monitor |
| Medtronic Vascular, INC. | $14.36 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Banu Mahalingham listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.